210 related articles for article (PubMed ID: 15014451)
21. Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma.
Geoerger B; Vassal G; Opolon P; Dirven CM; Morizet J; Laudani L; Grill J; Giaccone G; Vandertop WP; Gerritsen WR; van Beusechem VW
Cancer Res; 2004 Aug; 64(16):5753-9. PubMed ID: 15313916
[TBL] [Abstract][Full Text] [Related]
22. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
23. [Variants of adenovirus type 5 with deletions in early genes: ability for selective replication in p53-defective human tumor cells].
Kachko AV; Sviatchenko VA; Ternovoĭ VA; Kiselev NN; Sorokin AV; Kiselev SL; Georgiev GP; Netesov SV
Mol Biol (Mosk); 2003; 37(5):868-75. PubMed ID: 14593924
[TBL] [Abstract][Full Text] [Related]
24. E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies.
Wang G; Li G; Liu H; Yang C; Yang X; Jin J; Liu X; Qian Q; Qian W
J Gene Med; 2009 Jun; 11(6):477-85. PubMed ID: 19340843
[TBL] [Abstract][Full Text] [Related]
25. E1A and E1B proteins inhibit inflammation induced by adenovirus.
Schaack J; Bennett ML; Colbert JD; Torres AV; Clayton GH; Ornelles D; Moorhead J
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3124-9. PubMed ID: 14976240
[TBL] [Abstract][Full Text] [Related]
26. E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.
Kim J; Kim JH; Choi KJ; Kim PH; Yun CO
Hum Gene Ther; 2007 Sep; 18(9):773-86. PubMed ID: 17725410
[TBL] [Abstract][Full Text] [Related]
27. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
Nettelbeck DM; Rivera AA; Balagué C; Alemany R; Curiel DT
Cancer Res; 2002 Aug; 62(16):4663-70. PubMed ID: 12183423
[TBL] [Abstract][Full Text] [Related]
28. Analysis of early region 1 of porcine adenovirus type 3.
Zhou Y; Tikoo SK
Virology; 2001 Dec; 291(1):68-76. PubMed ID: 11878877
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus lacking the 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cells.
Duque PM; Alonso C; Sánchez-Prieto R; Lleonart M; Martínez C; de Buitrago GG; Cano A; Quintanilla M; Ramon y Cajal S
Cancer Gene Ther; 1999; 6(6):554-63. PubMed ID: 10608352
[TBL] [Abstract][Full Text] [Related]
30. A simple method for the simultaneous detection of E1A and E1B in adenovirus stocks.
Suzuki E; Murata T; Watanabe S; Kujime Y; Hirose M; Pan J; Yamazaki T; Ugai H; Yokoyama KK
Oncol Rep; 2004 Jan; 11(1):173-8. PubMed ID: 14654922
[TBL] [Abstract][Full Text] [Related]
31. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
[TBL] [Abstract][Full Text] [Related]
32. Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses.
Schmitz M; Graf C; Gut T; Sirena D; Peter I; Dummer R; Greber UF; Hemmi S
Gene Ther; 2006 Jun; 13(11):893-905. PubMed ID: 16482201
[TBL] [Abstract][Full Text] [Related]
33. Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus.
Horst Mt; Brouwer E; Verwijnen S; Rodijk M; de Jong M; Hoeben R; de Leeuw B; Smitt PS
J Gene Med; 2007 Dec; 9(12):1071-9. PubMed ID: 17902184
[TBL] [Abstract][Full Text] [Related]
34. Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.
Kirn D
Oncogene; 2000 Dec; 19(56):6660-9. PubMed ID: 11426652
[TBL] [Abstract][Full Text] [Related]
35. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.
Nemunaitis J; Ganly I; Khuri F; Arseneau J; Kuhn J; McCarty T; Landers S; Maples P; Romel L; Randlev B; Reid T; Kaye S; Kirn D
Cancer Res; 2000 Nov; 60(22):6359-66. PubMed ID: 11103798
[TBL] [Abstract][Full Text] [Related]
36. E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
Rao XM; Tseng MT; Zheng X; Dong Y; Jamshidi-Parsian A; Thompson TC; Brenner MK; McMasters KM; Zhou HS
Cancer Gene Ther; 2004 Sep; 11(9):585-93. PubMed ID: 15338010
[TBL] [Abstract][Full Text] [Related]
37. Oncolytic virotherapy for prostate cancer by E1A, E1B mutant adenovirus.
Satoh M; Wang H; Ishidoya S; Abe H; Moriya T; Hamada H; Arai Y
Urology; 2007 Dec; 70(6):1243-8. PubMed ID: 18158069
[TBL] [Abstract][Full Text] [Related]
38. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.
Fueyo J; Gomez-Manzano C; Alemany R; Lee PS; McDonnell TJ; Mitlianga P; Shi YX; Levin VA; Yung WK; Kyritsis AP
Oncogene; 2000 Jan; 19(1):2-12. PubMed ID: 10644974
[TBL] [Abstract][Full Text] [Related]
39. A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy.
Leja J; Dzojic H; Gustafson E; Oberg K; Giandomenico V; Essand M
Clin Cancer Res; 2007 Apr; 13(8):2455-62. PubMed ID: 17438105
[TBL] [Abstract][Full Text] [Related]
40. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.
Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS
Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]